208 related articles for article (PubMed ID: 36122624)
1. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE
Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624
[TBL] [Abstract][Full Text] [Related]
2. Evidence for ceramide induced cytotoxicity in retinal ganglion cells.
Fan J; Liu J; Liu J; Chen C; Koutalos Y; Crosson CE
Exp Eye Res; 2021 Oct; 211():108762. PubMed ID: 34499916
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.
Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury.
Fan J; Wu BX; Crosson CE
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4476-84. PubMed ID: 27571014
[TBL] [Abstract][Full Text] [Related]
5. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
6. Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls.
Lea SR; Metcalfe HJ; Plumb J; Beerli C; Poll C; Singh D; Abbott-Banner KH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2139-2147. PubMed ID: 27660431
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
8. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
[TBL] [Abstract][Full Text] [Related]
9. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.
Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J
J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266
[TBL] [Abstract][Full Text] [Related]
10. Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo.
Risner ML; Ribeiro M; McGrady NR; Kagitapalli BS; Chamling X; Zack DJ; Calkins DJ
Cell Commun Signal; 2023 Oct; 21(1):305. PubMed ID: 37904133
[TBL] [Abstract][Full Text] [Related]
11. 27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells.
Zhou Q; Band MR; Hernandez A; Liu ZL; Kummerow FA
Life Sci; 2004 Aug; 75(13):1567-77. PubMed ID: 15261762
[TBL] [Abstract][Full Text] [Related]
12. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal.
Cifone MG; Roncaioli P; De Maria R; Camarda G; Santoni A; Ruberti G; Testi R
EMBO J; 1995 Dec; 14(23):5859-68. PubMed ID: 8846779
[TBL] [Abstract][Full Text] [Related]
13. Relationships between ocular surface sphingomyelinases, Meibum and Tear Sphingolipids, and clinical parameters of meibomian gland dysfunction.
Sanchez V; Galor A; Jensen K; Mondal K; Mandal N
Ocul Surf; 2022 Jul; 25():101-107. PubMed ID: 35714913
[TBL] [Abstract][Full Text] [Related]
14. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.
Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA
J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762
[TBL] [Abstract][Full Text] [Related]
15. Characterization of acidic and neutral sphingomyelinase activities in crude extracts of HL-60 cells.
Samet D; Barenholz Y
Chem Phys Lipids; 1999 Nov; 102(1-2):65-77. PubMed ID: 11001562
[TBL] [Abstract][Full Text] [Related]
16. Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats.
Pérez-Villavicencio R; Flores-Estrada J; Franco M; Escalante B; Pérez-Méndez O; Mercado A; Bautista-Pérez R
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270028
[TBL] [Abstract][Full Text] [Related]
17. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase.
Jana A; Pahan K
J Neurosci; 2004 Oct; 24(43):9531-40. PubMed ID: 15509740
[TBL] [Abstract][Full Text] [Related]
19. Role of sphingomyelinases in neurological disorders.
Ong WY; Herr DR; Farooqui T; Ling EA; Farooqui AA
Expert Opin Ther Targets; 2015; 19(12):1725-42. PubMed ID: 26243307
[TBL] [Abstract][Full Text] [Related]
20. Lack of Acid Sphingomyelinase Induces Age-Related Retinal Degeneration.
Wu BX; Fan J; Boyer NP; Jenkins RW; Koutalos Y; Hannun YA; Crosson CE
PLoS One; 2015; 10(7):e0133032. PubMed ID: 26168297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
